News for OptimizeRx Corporation (OPRX)

No Stockholder Action Required at this Time WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the ”œCompany”) ( OPRX), a leading provi

OptimizeRx (OPRX) has confirmed that it has received a purported notice of nominations from a stockholder, Whetstone Capital Advisors, regarding its intention t

Silvestro has a demonstrated record of accelerating revenue growth, expanding brand relevance, and building a market-leading team WALTHAM, Mass., March 10, 2

OptimizeRX (OPRX) gains as a holder wants the company to explore a sale

OptimizeRx downgraded to "sector perform" by RBC amid slower growth outlook

OptimizeRx CEO to step down, interim successor named

OptimizeRx Corporation (NASDAQ:OPRX) Q3 2024 Results Earnings Conference Call November 13, 2024 4:30 PM ETCompany ParticipantsWilliam Febbo - Chief...

OptimizeRx (OPRX) delivered earnings and revenue surprises of 100% and 14.55%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

OptimizeRx (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions...

Optimizerx stock hits 52-week low at $6.29 amid market shifts

OptimizeRx (OPRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

WALTHAM, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology...

The availability of Micro-Neighborhood® Targeting on the Company’s Dynamic Audience Activation Platform meets the demand of life sciences marketers by...

Loading... Loading... Shares of Bolt Biotherapeutics, Inc. BOLT fell sharply during Wednesday's session after the company reported first-quarter financial resu...

Spok Holdings recently saw a decline in its stock price without a reasonable justification, in my view. Find out if now is a good time to buy SPOK stock.

We last covered MedAdvisor in December 2019, when CEO Robert Read expected the US to be the company’s biggest business within five years.

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

Read Analyzing ZipLink (OTCMKTS:ZIPL) & OptimizeRx (NASDAQ:OPRX) at ETF Daily News